$MKC·4

MCCORMICK & CO INC · Mar 28, 4:23 PM ET

MCCORMICK & CO INC 4

4 · MCCORMICK & CO INC · Filed Mar 28, 2014

Insider Transaction Report

Form 4
Period: 2014-03-26
BEARD PAUL C
Senior VP- Finance & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock - Voting

    2014-03-27$38.35/sh+17,550$673,04348,129 total
  • Exercise/Conversion

    Common Stock - Voting

    2014-03-27$32.83/sh+9,225$302,85739,804 total
  • Exercise/Conversion

    Common Stock - Non Voting

    2014-03-27$38.35/sh+3,850$147,6488,743 total
  • Sale

    Common Stock - Non Voting

    2014-03-27$71.00/sh3,850$273,3504,893 total
  • Sale

    Common Stock - Non Voting

    2014-03-27$71.00/sh3,075$218,3254,893 total
  • Exercise/Conversion

    Options - Right to Buy

    2014-03-279,2250 total
    Exercise: $32.83From: 2007-02-28Exp: 2016-02-27Common Stock - Voting (9,225 underlying)
  • Exercise/Conversion

    Options - Right to Buy

    2014-03-273,0750 total
    Exercise: $32.83From: 2007-02-28Exp: 2016-02-27Common Stock - Non Voting (3,075 underlying)
  • Exercise/Conversion

    Options - Right to Buy

    2014-03-2717,5500 total
    Exercise: $38.35From: 2006-01-25Exp: 2015-01-24Common Stock - Voting (17,550 underlying)
  • Sale

    Common Stock - Voting

    2014-03-27$71.00/sh17,550$1,246,05030,579 total
  • Sale

    Common Stock - Voting

    2014-03-27$71.00/sh9,225$654,97530,579 total
  • Exercise/Conversion

    Common Stock - Non Voting

    2014-03-27$32.83/sh+3,075$100,9527,968 total
  • Award

    Options - Right to Buy

    2014-03-26+17,20017,200 total
    Exercise: $71.10Exp: 2024-03-25Common Stock - Voting (17,200 underlying)
  • Exercise/Conversion

    Options - Right to Buy

    2014-03-273,8500 total
    Exercise: $38.35From: 2006-01-25Exp: 2015-01-24Common Stock - Non Voting (3,850 underlying)
Footnotes (2)
  • [F1]The grants vest in thirds over a three year period, beginning on the first anniversary date.
  • [F2]Option exercised.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT